Home » Topics » BioWorld

BioWorld
RSS

NEWS BRIEFS

Jan. 4, 1991

010491PATENTS1

Jan. 4, 1991

RELATED PATENTS

Jan. 4, 1991

BIOWORLD'S STOCK CONTEST PICKS

Jan. 4, 1991

1991 TOP STOCK PICKS

Jan. 4, 1991

NEW PATENT BRINGS NEW SUIT IN PCR DISPUTE

Jan. 4, 1991

AMGEN LED BIOTECH STOCKS IN 1990

Jan. 3, 1991

EPO APPROVED TO TREAT AIDS-RELATED ANEMIA

Jan. 3, 1991

NEORX RESTRUCTURES, CUTS WORK FORCE

Jan. 2, 1991

SALE SIGNALS END OF THE LINE FOR LIPOGEN

Jan. 2, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...